---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-120197"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:40:20.946073+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology raises $18M in registered direct & private placement; funds LYMPHIR launch

## Summary
- Gross proceeds ~$18M from sale of 1,284,404 shares at $1.09 + 15,229,358 pre-funded warrants at $1.0899 per unit.
- Net proceeds ~$15.2M after fees; H.C. Wainwright acted as placement agent (7% fee).
- Concurrent private placement includes warrants exercisable at $1.09 upon stockholder approval, 5-year term.
- Existing warrants for 11,961,040 shares amended to $1.09 exercise price and exercisable after stockholder approval.
- Citius Pharma promissory note maturity amended to require $50M of gross proceeds raised before maturity.

## SEC filing metadata
- accession: 0001213900-25-120197
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/0001213900-25-120197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/ea0269093-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-120197
- JSON: https://secwatch.observer/filing/0001213900-25-120197.json
- Plain text: https://secwatch.observer/filing/0001213900-25-120197.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.